Navigation Links
More kidney cancer is detected and treated early, yet death rate rises

The number of cases of kidney cancer has been rising over the last two decades, and new research from the University of Michigan Comprehensive Cancer Center shows that this increase is driven largely by the detection of small, presumably curable, kidney masses. But even though the rising incidence has been paralleled by greater use of surgery for kidney cancer, this trend has not led to fewer people dying.

"With increased early detection and treatment of small tumors, we would expect to see a decrease in mortality associated with kidney cancer," says senior author Brent K. Hollenbeck, M.D., assistant professor of urology at the U-M Medical School. "Surprisingly, that's not what we found. Our research shows that an increase in detection and treatment is not leading to a reduction in the kidney cancer mortality rate."

The study ?published in the Sept. 20 issue of the Journal of the National Cancer Institute ?includes data from nine of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries. In all, the researchers examined data from 34,503 patients with kidney cancer.

Over the study period (1983 to 2002), researchers observed a rise in the occurrence of kidney cancer (also known as renal cell carcinoma) for tumors of all sizes. But the greatest increases in kidney cancer incidence were among tumors 4 centimeters or smaller. Tumors of this size, often found in patients without any clinical signs or symptoms, are being detected more and more with the widespread use of abdominal imaging studies, such as MRIs and CAT scans. These small kidney tumors are considered curable by surgery, which has led to a rise in surgery for kidney cancer.

Even as early detection and surgical treatment increased, however, mortality rates caused by kidney cancer during the time period rose dramatically, from 1.2 to 3.2 deaths per 100,000 people in the United States.

These seemingly contradictory findings can b
'"/>

Source:University of Michigan Health System


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
3. NASA links nanobacteria to kidney stones and other diseases
4. New type of rejection blocker protects kidneys after transplant
5. New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease
6. Scientists discover that widely available drug also helps fight kidney disease
7. Gene discovery may shed light on kidney disease
8. U of M study examines kidney stone prevention in astronauts
9. Scientists solve 30-year-old mystery of mutant mouses kidney woes
10. Key gene controlling kidney development found
11. Mutant gene causes severe kidney disease in infants

Post Your Comments:
(Date:11/24/2009)... constitutes fish food is a matter of debate. A hi...sh get almost 50 percent of their carbon from tree...en the terrestrial and aquatic ecosystems. , But...ows this is not likely to be true. Algae provide a... according to research published this week in the ...
(Date:11/23/2009)...NNATINew research presents strong evidence that th...oth outdoor traffic-related pollution and indoor e... one or the other exposure alone. , Environmen...ati (UC) College of Medicine have shown that child... particles and indoor endotoxin during early life ...
(Date:11/23/2009)...ONTO, November 23, 2009 - The time of day matters ... a new paper produced by a research team led by Pr...arborough,s vice-principal for research and collea... at the St. George campus. , Capitalizing on t...lar tree, the research team examined how poplar tr...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 1Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 3Telik Announces Third Quarter 2009 Financial Results 6261 1Telik Announces Third Quarter 2009 Financial Results 6261 2Telik Announces Third Quarter 2009 Financial Results 6261 3Hip Fracture Odds Rise With Womens Age 61338 1
...may be one step closer to finding new drugs to fig... leading bioservices organisation announced that i...rsity of Strathclyde. , CABI houses one of the wor..., numbered at over 28,000 strains, including Flemi...will be supplying the University of Strathclyde’s ...
...lated neurological diseases are associated with de...esting that the cell’s normal disposal mechanisms ...he University of Pennsylvania School of Medicine h... two major pathways for breaking down proteins and...degenerative diseases in a simple animal model. Th...
...s have discovered the most effective method yet to...ture’s most abundant sugar, to HFM, a chemical tha...ade from petroleum. It has been an elusive goal f...eplace crude oil as the root source for plastic, f...chemicals with inexpensive, nonpolluting renewable...
Other Biology News:Could fungal collection hold the key to new life-saving drugs? 2Penn researchers link cell's protein recycling systems 2Penn researchers link cell's protein recycling systems 3Plastic that grows on trees 2Plastic that grows on trees 3
(Date:11/25/2009)...dor to Speak at Economic Club of Canada , ...25, 2009 -- Ambassador to Speak at Economic Club o...sador for International Investment, and Chairman a...iography of David Appia go to www.investinfrance....o meet with press to discuss recent pro-business i...
(Date:11/25/2009)...-Asia/--SinovacBiotechLtd.(SVA),aleadingdeveloper...,ajointventure(JV)agreementtoestablishSinovac(Dali...willresearch,develop,produce,andcommercializehuman...experienceindevelopingandcommercializingworld-clas...manufacturingfacilitiesand,establishedoperatinginf...
(Date:11/24/2009)...German . , Whether it,s CD packaging, contai...quency Identification) are increasingly finding th...to label objects or goods and identify them automa...r can read and process the data contained in the l...roduction conditions of up to 100 degrees Celsius....
(Date:11/24/2009)... York investment bank KTA Capital,s client Neuren ... mil convertible note private placement with a U.S...s arranged by KTA Capital as Neuren,s exclusive pl... New York (PRWEB) November 23, 2009 -- The inde...("KTA Capital") has announced that its c...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...GO, Aug. 18 LifeVantage Corporation,(OTC Bulletin... product,clinically proven to slow the progressive... President & CEO, David Brown, is featured in an,e...Show., The interview gives viewers an overview of...s latest press release., To view the clip in i...
..., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye ...ard: YGYB) ("Yongye" or the "Company"),a leading d...r plants and,animals in the People,s Republic of C...e quarter ended June 30, 2008., Second Quarter 2...ncrease of 136.6% from the second quarter of 2...
...LPHIA, Aug. 17 /Xinhua-PRNewswire/ -- WuXi AppTec,...YSE: WX ) in the U.S., has announced,the appointm...erations and,Joseph Hughes, Ph.D. as Vice Presiden...y., (Logo: http://www.newscom.com/cgi-bin/prnh/2...e company for nine years in roles of,increasing re...
Other Biology Technology:[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2Yongye Biotechnology International Announces Second Quarter Results 2Yongye Biotechnology International Announces Second Quarter Results 3Yongye Biotechnology International Announces Second Quarter Results 4Yongye Biotechnology International Announces Second Quarter Results 5Yongye Biotechnology International Announces Second Quarter Results 6Yongye Biotechnology International Announces Second Quarter Results 7Yongye Biotechnology International Announces Second Quarter Results 8Yongye Biotechnology International Announces Second Quarter Results 9Yongye Biotechnology International Announces Second Quarter Results 10Yongye Biotechnology International Announces Second Quarter Results 11WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rat Anti-Mouse Granzyme D Monoclonal Antibody, Unconjugated, Clone 190617 from R&D Systems
Mouse Anti-Human ADAM10 Ectodomain Monoclonal Antibody, Unconjugated, Clone 163003 from R&D Systems
Anti-Human Apolipoprotein B100 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: